HASLER HANS PETER - 10 Jun 2022 Form 4 Insider Report for Minerva Neurosciences, Inc. (NERV)

Role
Director
Signature
/s/ Marc Recht, Attorney-in-Fact
Issuer symbol
NERV
Transactions as of
10 Jun 2022
Transactions value $
$0
Form type
4
Filing time
28 Jun 2022, 19:34:39 UTC
Previous filing
16 Jun 2021
Next filing
22 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NERV Stock Option (right to buy) Award $0 +2,500 $0 2,500 10 Jun 2022 Common Stock 2,500 $3.32 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is granted to non-employee directors in accordance with the Issuer's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 2,500 shares of common stock per year.
F2 On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock ("Reverse Stock Split"). This amount has been adjusted to give effect to the Reverse Stock Split.
F3 The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 10, 2022 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date.